Evidence map›Paper›PMID 39610405›Full record

ArticleOpen forum infectious diseases2024

Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive Messaging.

Molly L Paras, Lisa M Chirch, Mariam Aziz, Gayle P Balba, Constance Benson, Saira Butt, Scott H James, Todd P McCarty, Raymund Razonable, Rebecca Reece and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Molly L ParasDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-6658-8634
Lisa M ChirchDivision of Infectious Disease, University of Connecticut School of Medicine, Farmington, Connecticut, USA.ORCID https://orcid.org/0000-0002-8660-8070
Mariam AzizDivisions of Infectious Diseases and Community and Global Health Equity, Rush University Medical Center, Chicago, Illinois, USA.
Gayle P BalbaDivision of Infectious Diseases, Medstar Georgetown University Hospital, Georgetown University School of Medicine, Washington, District of Columbia, USA.
Constance BensonDivision of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.ORCID https://orcid.org/0000-0002-3781-1347
Saira ButtDivision of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID https://orcid.org/0000-0003-3273-8379
Scott H JamesDivision of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Todd P McCartyDivision of Infectious Diseases, University of Alabama at Birmingham, and Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA.
Raymund RazonableDivision of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0001-5248-0227
Rebecca ReeceDivision of Infectious Diseases, West Virginia University School of Medicine, Morgantown, West Virginia, USA.
Rachel ShnekendorfInfectious Diseases Society of America, Arlington, Virginia, USA.
Talia H SwartzDivision of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID https://orcid.org/0000-0003-1572-045X
J Alex ViehmanDivision of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Vera P LutherSection on Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID https://orcid.org/0000-0002-9331-0918
Infectious Diseases Society of America Fellowship Training Program Directors Community of Practice and Working Group (complete list of contributing authors in the Working Group listed in acknowledgments)

Funding

Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials UnitUM1AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK · 2012 to 2026
$44.8M
NIAID NIH HHS UM1 AI069470
6 · The paper itself

Abstract

The field of infectious diseases (ID) offers a rewarding career path and is widely viewed as an essential subspecialty in medicine. However, in recent years, these positive aspects have been overshadowed by concerns surrounding low fellowship match rates, undercompensation, and burnout. The Infectious Diseases Society of America Fellowship Training Program Directors Committee met in 2023, discussed the future of ID as a specialty, and sought to develop strategies to highlight the value and opportunities of ID for future generations, as well as underscore the importance of and provide tools for positive messaging to trainees about the subspecialty. This paper presents ideas generated at this meeting and is meant to serve as a reference for ID training program directors, as well as the wider ID community, in uplifting and shaping the future of the field.

Indexed as

infectious diseases fellowshipmedical educationpositive messagingvalue

Identifiers

PMID39610405
PMCPMC11604074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.